Cadmium, a highly ubiquitous toxic heavy metal, has been widely recognized as an environmental and industrial pollutant, which confers serious threats to human health. The molecular mechanisms of the cadmium-induced cardiotoxicity (CIC) have not been studied in human cardiomyocytes at the cellular level. Here we showed that human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) can recapitulate the CIC at the cellular level. The cadmium-treated hPSC-CMs exhibited cellular phenotype including reduced cell viability, increased apoptosis, cardiac sarcomeric disorganization, elevated reactive oxygen species, altered action potential profile and cardiac arrhythmias. RNA-sequencing analysis revealed a differential transcriptome profile and activated MAPK signalling pathway in cadmium-treated hPSC-CMs, and suppression of P38 MAPK but not ERK MAPK or JNK MAPK rescued CIC phenotype. We further identified that suppression of PI3K/Akt signalling pathway is sufficient to reverse the CIC phenotype, which may play an important role in CIC. Taken together, our data indicate that hPSC-CMs can serve as a suitable model for the exploration of molecular mechanisms underlying CIC and for the discovery of CIC cardioprotective drugs.
hypertension and arteriosclerosis, stroke and heart failure. [17] [18] [19] [20] [21] [22] [23] Cadmium-induced cardiotoxicity (CIC) has been studied mainly in cultured cardiomyocytes isolated from murine models. [24] [25] [26] [27] [28] [29] [30] However, animal models cannot accurately recapitulate the CIC because of the large difference in gene expression profile, electrophysiology and contractile features, and responses to specific therapies between murine and human cardiac systems. Human pluripotent stem cellderived cardiomyocytes (hPSC-CMs) offers a human-based, physiology-relevant and scalable cell source for disease modelling and drug screening. [31] [32] [33] [34] [35] Several studies have demonstrated the reliability of hPSC-CMs to study drug-induced cardiotoxicity in a dish, which encourages us to investigate the CIC using hPSC-CMs. [36] [37] [38] [39] [40] [41] [42] [43] [44] In this study, we utilized hPSC-CM as a unique platform to investigate the molecular mechanisms of CIC. We observed cellular phenotype in Cd-treated hPSC-CMs, including reduced cell viability, increased apoptosis, cardiac sarcomeric disorganization, elevated reactive oxygen species (ROS), altered electrophysiology and cardiac arrhythmias, when compared to control cells. RNA-Sequencing (RNA-Seq) analyses revealed a differential transcriptome profile and activated MAPK signalling pathway in Cd-treated hPSC-CMs, and suppression of P38 MAPK rescued CIC phenotype. We further identified that suppression of PI3K/Akt signalling pathway is sufficient to reverse the CIC phenotype, which may play an important role in CIC. Taken together, it is the first in vitro stem cell model to study CIC, which provides a suitable model for the exploration of molecular mechanisms underlying CIC and for the discovery of CIC cardioprotective drugs.
| MATERIALS AND METHODS

| Culture and maintenance of H9 human embryonic stem cells
H9 human embryonic stem cells (hESCs) were utilized in this study, which were obtained from WiCELL (Madison, WI). Cells were cultured in feeder-free mTeSR1 (STEMCELL Technologies) media on matrigel-coated (Corning) plates at 37°C with 5% (vol/vol) CO 2 . The media were daily changed, and cells were passaged every 3-4 days using StemPro Accutase (Gibco).
| Cardiac differentiation
H9 hESCs were differentiated into cardiomyocytes (CMs) using a 2D monolayer differentiation protocol as previously described. 45 Briefly, 10 5 undifferentiated cells were dissociated and re-plated into matrigel-coated 6-well plates. Cells were cultured and expanded to 85% cell confluence and then treated for 2 days with 6 lmol/L CHIR99021 (Axon Medchem) in RPMI and B-27 supplement minus insulin (RPMI+B27-Insulin) (Gibco) to activate Wnt signalling pathway. On day 2, cells were placed in RPMI+B27-Insulin with CHIR99021 removal. On days 3-4, cells were treated with 5 lmol/L IWR-1 (Axon Medchem) to inhibit Wnt signalling pathway. On days 5-6, cells were removed from IWR-1 treatment and placed in RPMI+B27-Insulin. From day 7 onwards, cells were placed and cultured in RPMI and B-27 supplement with insulin (RPMI+B27 + Insulin) (Gibco) until beating was observed. Cells were glucose starved for 3 days with RPMI+B27 + Insulin for the hPSC-CM purification. 46 H9-CMs of Day 30-40 after cardiac differentiation were utilized for cadmium induction and downstream functional assays in this study.
| Caspase-3 activity assay
Caspase 3 activities were performed using caspase 3 Assay Kit (Beyotime) according to the manufacturer 0 s instructions. H9-CMs were digested with Trypsin-EDTA (Gibco) and collected by centrifugation at 600 g for 5 minutes at 4°C. The cell pellets were washed with DPBS (Gibco) and re-suspended in 1 9 lysis buffer at a concentration of 100 lL per 2 million cells, incubated on ice for 15 minutes and then centrifuged at 16 000-20 000 g for 10-15 minutes at 4°C. Appropriate amount of protein was put in a 96-well plate, and 10 lL of Ac-DEVD-pNA (acetyl-Asp-Glu-Val-Asp p-nitroanilide) (2 mmol/L) was added per well and then incubated for 60-120 minutes at 37°C. Absorbance at 405 nm was read using a MD M5 SpectraMax reader (Molecular Devices).
| High-content imaging
H9-CMs were cultured in Matrigel-coated 24-well plate. Time-lapse live cell imaging was performed using an Operetta High-Content Imaging System (PerkinElmer) at 209 magnification. Images were then analysed with Harmony4.1 (PerkinElmer).
| Transmission electron microscopy
H9-CMs were dissociated with Tripsin-EDTA, scrapped into a 1.5-mL microcentrifuge tube and centrifuged and then fixed with cold 2.5%-glutaraldehyde in 0.1 mol/L phosphate buffer overnight at 4°C.
The specimen was postfixed with 1% OsO 4 in phosphate buffer and dehydrated by a graded series of ethyl-alcohol (30%, 50%, 70%, 80%, 90%, 95% and 100%) for 15-20 minutes at each step and then transferred to absolute acetone for 20 minutes. The specimen was placed in 1:1 mixture of absolute acetone and final spur resin mixture for 1 hour at room temperature, and transferred to 1:3 mixture of absolute acetone and final spur resin mixture for 3 hours, and then transferred to final spur resin mixture overnight. The specimen was placed in 1.5-mL tube contained spur resin, heated at 70°C for more than 9 hours and sectioned using a LEICA EM UC7 ultratome.
The sections were then stained with uranyl acetate and alkaline lead citrate for 5-10 minutes. Pictures were observed using a transmission electron microscopy (Hitachi, Model H-7650).
| Reactive oxygen species (ROS) assay
Cellular levels of ROS in H9-CMs were determined using a Reactive Oxygen Species Assay Kit (Beyotime) according to the manufacturer's instructions.
| Electrophysiology
H9-CMs were mechanically and enzymatically dissociated to obtain single cells, which were seeded on Matrigel-coated glass coverslips (Warner Instruments). Cells with spontaneous beatings were selected, and action potentials were recorded using an EPC-10 patch clamp amplifier (HEKA). Continuous extracellular solution perfusion was achieved using a rapid solution exchanger (Bio-logic Science Instruments). Data were acquired using PatchMaster software (HEKA) and digitized at 1 kHz. Data analyses were performed using Igor Pro (Wavemetrics) and Prism (Graphpad). A TC-344B heating system (Warner Instruments) 
| RNA-sequencing
RNA purity was checked using the Nano Photometerâ spectrophotometer (IMPLEN), and RNA concentration was measured using Qubitâ RNA Assay Kit in Qubitâ 2.0 Flurometer (Life Technologies).
RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies). The transcriptome library for sequencing was generated using VAHTSTMmRNA- into raw reads by base calling using CASAVA (http:// www.illumina.com/support/documentation.ilmn). Then, raw reads in a fastq format were first processed using in-house perl scripts. Clean reads were obtained by removing reads with adapters, reads in which unknown bases were more than 5% and low quality reads (the percentage of low quality bases was over 50% in a read, we defined the low quality base to be the base whose sequencing quality was no more than 10). At the same time, Q20, Q30, GC content of the clean data were calculated. After initial quality control, the SHEN ET AL.
| 4223 clean reads were mapped to the reference sequence by using TopHat2 software (v2.1.1). The alignment files generated by TopHat2 were input to the Cufflinks software (v2.2.1), which is a program for the comparative assembly of transcripts and the estimation of their abundance in a transcriptome sequencing experiment using the measurement unit FPKM (fragments per kilobase of transcript per million mapped reads). After using Cuffmerge program to merge transcripts of each sample in different materials and stages into a single gtf file that was used to identify differentially expressed genes, we used Cuffdiff program to find DEGs (differentially expressed genes). The differentially expressed genes were identified with q value ≤0.05 and a fold change of ≥2 between control and 
| Quantitative real-time PCR (qPCR)
Total RNA isolation from hESC-CMs was performed using RNeasy Mini Kit (Qiagen). RNA concentration was measured using UV spectrophotometry at 260 nm (Nanodrop 2000, Thermo Scientific).
cDNA was obtained using the High Capacity cDNA Reverse transcription Kit (Applied Biosystems). qPCR was performed using SYBR Green PCR Master Mix (Takara). Primer sequences used in this study are listed in Table S1 . Each reaction was run in triplicates using an Applied Biosystems Viia7 Dx (Thermo Fisher Scientific). Gene expression values were normalized to the average expression of housekeeping gene GAPDH.
| Western blot
H9-CMs were grown in 6-well plates to 80% confluence, detached with TrypLE (Gibco) and then pelleted at 12 000 rpm for 3-5 minutes at 4°C. After washing with DPBS (Sangon Biotech), the pellets were re-suspended in 50-100 lL lysis buffer. Lysates were placed on ice for 30 minutes, and then, the supernatants were collected after centrifuging at 12 000 rpm for 5 minutes. Protein concentration was measured using a BCA kit (Pierce). Western blot was performed using standard protocol with the following antibodies: caspase 3 (Cell Signaling Technology), phosphorylated P38 (Cell Signaling Technology), total P38 (Cell Signaling Technology), total c-Myc (Cell Signaling Technology), phosphorylated Akt (Cell Signaling Technology) and total Akt (Cell Signaling Technology).
| Compounds and solutions
All the chemicals used in the electrophysiological experiments were purchased from Sigma-Aldrich. Cadmium chloride (CdCl 2 ) was purchased from Sigma-Aldrich, and stock solutions were prepared in 100 mmol/L in H 2 O. When CdCl 2 induction performed, a new vial of stock solution was used and dilutions were prepared within 30 minutes of induction. Escalating doses of CdCl 2 (0.1, 1, 3, 10, 30 and 100 lmol/L) were firstly used for the dose-response experiments. For downstream investigations in this study, H9-CMs were all treated with 30 lmol/L CdCl 2 for 24 hours, and functional assays were performed at this condition. PD0325901, SB203580, SP600125 and Ly294002 were all purchased from Selleck. Z-VAD-FMK, catechin hydrate and geldanamycin were all purchased from Beyotime. Detailed information of each compound used in this study is listed in Table S2 . 
| Statistical analysis
| RESULTS
| Generation of H9 human embryonic stem cellderived cardiomyocytes (H9-CMs)
H9 embryonic stem cells (H9) were utilized for generation of cardiomyocytes (CMs), which exhibited typical stem cell morphology and stained positive for pluripotency markers (Nanog, SSEA-4, Oct4
and Sox2) and alkaline phosphatase (Figure S1A-C). We used a 2D in vitro monolayer protocol to differentiate H9 hESCs into CMs, which can give rise to a yield of >90% after purification indicated by FACS analysis ( Figure S1D ,E, Videos S1 and S2). The monolayer H9 hESC-derived cardiomyocytes (H9-CMs) were then mechanically and enzymatically dissociated into single cells, which exhibited positive staining of cardiac markers of TNNT2 and a-actinin ( Figure S1F ).
| Cadmium-induced morphological changes and apoptosis in H9-CMs
We first sought to determine whether cadmium can induce morphological changes and cell death in H9-CMs. Previous studies have investigated cadmium-induced cytotoxicity in different cell types within a range of 0-300 lmol/L. [47] [48] [49] [50] [51] [52] [53] Therefore, cells were exposed to escalating concentrations of cadmium chloride (CdCl 2 ) from 0.1 to 100 lmol/L for 24 hours, and significantly morphological changes 
| Cadmium-induced elevated ROS in H9-CMs
| Cadmium-induced cardiac sarcomeric disorganization and ultrastructural changes in H9-CMs
Previous studies have shown histological abnormalities of heart tissue in rat when treated with cadmium. [24] [25] [26] [27] [28] [29] [30] We therefore assessed the extent of sarcomeric organization in H9-CMs by immunostaining with TNNT2 and a-actinin. As expected, control cells exhibited regular sarcomeric organization (Figures 2A,B and S6) . By contrast, 30 lmol/L CdCl 2 -treated cells showed a severe sarcomeric disorganization and disruption (Figures 2A,B and S6 ). To further assess the cell organelles in detail, we performed transmission electron microscope (TEM) in H9-CMs. We observed apparent cardiac sarcomeres in control cells, which were absent in 30 lmol/L CdCl 2 -treated ones.
Moreover, CdCl 2 -treated cells exhibited apoptotic signs including enlarged nucleocytoplasmic ratio and nuclear membrane shrinkage ( Figure S7 ). Collectively, these data suggest that cadmium results in cardiac sarcomere disorganization and disruption as well as ultrastructural changes in H9-CMs.
| Cadmium-induced action potential phenotype in H9-CMs
Cadmium exposure is associated with frontal T-wave axis deviation, an easily detected subclinical marker of ventricular arrhythmias in individuals without heart disease. 54 However, the effects of cadmium on in vitro cardiac electrophysiology have not been much studied yet. To investigate whether cadmium affects the electrophysiology of H9-CMs, we performed patch clamp to record action potentials in these cells ( Figure 3A,B and Table S3 ). Strikingly, an increased subfraction of 30 lmol/L CdCl 2 -treated cells were observed to exhibit arrhythmias including early afterdepolarizations (EADs) and delayed afterdepolarizations (DADs), when compared to control ones ( Figure 3A,B) . The 
| Cadmium-induced ion channel remodelling in
H9-CMs
We next performed qPCR to compare gene expression of a panel of cardiac ion channels between control and CdCl 2 -treated H9-CMs.
The majority of the ion channel genes were decreasingly expressed in 30 lmol/L CdCl 2 -treated cells, including SCN5A, KCND3, KCNH2, KCNJ3, KCNJ5, KCNJ11, HCN2 and HCN4 ( Figure 4A and Table S1 ). By contrast, expression of CACNA1C was significantly increased ( Figure 4A and Table S1 ). To investigate whether Table S4 ). In line with a previous study, 55 the Ca 2+ current density was significantly decreased in Table S5 ). These results suggest that cadmium leads to ion channel remodelling at the cellular level in H9-CMs.
| RNA-Seq analysis revealed differential transcriptome profile in cadmium-treated H9-CMs
To further analyse the molecular basis of CIC, we next performed genome-wide RNA-sequencing in both control and CdCl 2 -treated H9-CMs ( Figure 5A ). Principal component analysis (PCA) revealed that 30 lM CdCl 2 -treated samples clustered together separately from control ones ( Figure 5B ). We found that 1978 genes of 22052 total genes (1361 up-regulated, and 617 down-regulated) were differentially expressed in CdCl 2 -treated H9-CMs ( Figures 5C and S9) .
Several studies have implicated that increased expression of metallothionein (MT) and heat shock protein (HSP) genes was associated with cadmium-induced cytotoxicity. 23, 24, 26, 56 In line with the previous findings, we observed that the expression of numerous MT gene isoforms, heat shock protein family A (HSP70), DnaJ heat shock protein family (HSP40) was dramatically up-regulated in CdCl 2 -treated H9-CMs, as compared to control cells ( Figure 5D -F). Growth arrest and DNA-damage-inducible protein (GADD45) genes, including GADD45G, GADD45B and GADD45A, were also increasingly expressed, which have been implicated as key mediators of apoptotic cardiomyocyte death ( Figure 5G ). 57 Figure 5I ). Interestingly, gene ontology (GO) analysis revealed that genes were positively enriched in "regulation of cell death," "regulation of apoptotic process," "regulation of programmed cell death," "regulation of response to stimulus" and "regulation of response to stress" which are highly consistent with observed CIC ( Figure S10 and Table S6 ). Notably, ingenuity pathway analysis (IPA) revealed significant up-regulation of protein processing in mitogen-activated protein kinase (MAPK), NF-jB, gap junction, Wnt, ErbB, Jak-STAT and apoptosis signalling pathways in CdCl 2treated H9-CMs ( Figure 5J and Table S7 ). We therefore test whether blockade of specific signalling pathway F I G U R E 4 Cadmium-induced ion channel remodelling in H9-CMs. A, Bar graph to compare gene expression of major ion channels between control and 30 lmol/L CdCl 2 -treated H9-CMs, including SCN5A, KCND3, CACNA1C, KCNQ1, KCNH2, KCNJ2, KCNJ3, KCNJ5, KCNJ11, HCN2 and HCN4. *P < .05, **P < .01, ***P < .001 and ****P < .0001. B, Representative sodium current tracings isolated from control and 30 lmol/L CdCl 2 -treated H9-CMs. C, Comparison of sodium current-voltage relationship curve (IV curve) between control and CdCl 2 -treated H9-CMs. *P < .05 and ****P < .0001. D, Comparison of steady-state activation and steady-state inactivation of sodium current between control and CdCl 2 -treated H9-CMs. E, Representative calcium current tracings isolated from control and 30 lmol/L CdCl 2 -treated H9-CMs. F, Comparison of calcium current-voltage relationship curve (IV curve) between control and CdCl 2 -treated H9-CMs. ***P < .001 and ****P < .0001. G, Comparison of steady-state activation and steady-state inactivation of calcium current between control and CdCl 2 -treated H9-CMs can reverse cadmium-induced cellular phenotype. H9-CMs were exposed to 30 lmol/L CdCl 2 in the presence of PD0325901 (ERKspecific inhibitor, ERKi), SB203580 (P38-specific inhibitor, P38i) or SP600125 (JNK-specific inhibitor, JNKi), respectively. In comparison with H9-CMs treated with CdCl 2 alone, addition of SB203580 attenuated the CdCl 2 -induced apoptosis measured by TUNEL assay (Figure 6A,B) . In contrast, PD0325901 or SP600125 showed negligible effect on rescuing the CdCl 2 -induced cell apoptosis ( Figure 6A,B) . Figure 6D) . However, addition of SB203580, selectively targeting MAPKAPK2 and MAPKAPK3, effectively attenuated increased expression of c-Myc induced by CdCl 2 treatment (Figure 6E) . These data suggest that P38 MAPK signalling pathway is critical to CIC in H9-CMs and suppression of P38 can protect CIC.
| P38 MAPK signalling pathway is critical to CIC in H9-CMs
| Protection of CIC by suppressing PI3K-Akt signalling pathway in H9-CMs
Previous studies reported that PI3K/Akt signalling pathway was associated with cadmium-induced apoptosis in glial cells and proximal tubular cells. 47, 61 Our RNA-Seq data showed HSP90 genes (HSP90B1 and HSP90AB1) were highly expressed in CdCl 2 -treated H9-CMs, which may enhance phosphorylation of Akt to induce cell apoptosis ( Figures S12 and S13) . 62, 63 Above clues encouraged us to investigate whether PI3K-Akt signalling pathway plays an important greater rescuing effect than P38-specific inhibitor SB203580 (Figure 7A,B) . However, addition of Ly294002 and SB203580 together did not give rise to a further rescuing effect compared to Ly294002 alone, suggesting that PI3K-Akt and P38 MAPK pathways may share the same downstream target to regulate CIC in H9-CMs ( Figure 7A,B) .
Moreover, CdCl 2 -induced cell apoptosis was significantly rescued by geldanamycin, a HSP90 inhibitor, indicating that up-regulation of HSP90 is associated with CdCl 2 -induced apoptosis (Figure 7A,B) . In line with the TUNEL data, addition of Ly294002 effectively rescued 30 lmol/L CdCl 2 -induced electrophysiological phenotype, showing a normal action potential profile similar to control cells ( Figure 7C-I) . We further confirmed that phosphorylation of Akt (p-Akt) was activated in 30 lmol/L CdCl 2 -induced H9-CMs, whereas addition of Ly294002 or geldanamycin effectively reversed the increased level of p-Akt expression, suggesting that activated Akt is associated with cadmiuminduced apoptosis which is HSP90 dependent (Figure 7J,K) . However, there was no significant difference of total Akt expression between different groups ( Figure 7L ). Interestingly, similar rescuing effect was also observed in cells treated with CH, confirming that elevated cellular ROS is associated with enhanced PI3K/Akt signalling in CdCl 2 - Taken together, these data suggest that cadmium-induced elevation of HSP90 expression or ROS amount may activate PI3K-Akt signalling pathway, which is critical to CIC in H9-CMs and suppression of PI3K/ Akt is sufficient to protect CIC.
| DISCUSSION
Cardiovascular diseases rank No.1 morbidity and mortality worldwide. Cadmium, a highly ubiquitous toxic heavy metal, was shown to damage cardiovascular system, thus leading to cardiovascular diseases such as myocardial infarction, peripheral arterial disease, cardiomyopathy, hypertension and arteriosclerosis, stroke and heart failure. [17] [18] [19] [20] [21] [22] [23] Previous studies have shown that cadmium can induce apoptosis and is cardiotoxic in rat cardiomyocytes. [24] [25] [26] [27] [28] [29] [30] However, the mechanism by which cadmium causes the cardiotoxicity has not been studied in human cardiomyocytes at the cellular level. In this study, we show that, for the first time, 24, [26] [27] [28] [29] Effects of cadmium on the heart include effects of cardiac structure and integrity, as well as effects of cardiac conduction system. 23 However, the in vitro electrophysiology of CMs exposed to cadmium has not been well studied yet. We observed that, when GO analysis revealed that genes were positively enriched in "regulation of cell death," "regulation of apoptotic process," "regulation of programmed cell death," "regulation of response to stimulus" and "regulation of response to stress." IPA identified up-regulation of protein processing in MAPK, NF-jB, gap junction, Wnt, ErbB, Jak-STAT and apoptosis signalling pathways in CdCl 2 -treated H9-CMs.
We further found that P38 MAPK inhibitor partially protected Previous studies have reported that PI3K/Akt signalling pathway is associated with cadmium-induced apoptosis in different cell types. 47, 61, [71] [72] [73] [74] [75] Notably, 3 studies have shown that activation of PI3K/Akt signalling pathway led to cadmium-induced apoptosis in astrocytes, thyroid carcinoma cells and HK-2 renal proximal tubular epithelial cells, respectively. 47, 71, 74 Indeed, we identified in this study that PI3K/Akt inhibitor restored CdCl 2 -induced apoptosis and abnormal electrophysiology to control H9-CMs, supporting the sustained PI3K/Akt signalling pathway activation and Akt-mediated cardiotoxicity induced by cadmium.
In summary, our results suggest that hPSC-CMs can recapitulate the CIC in vitro. We found cadmium-induced elevation of ROS amount, and subsequent ROS accumulation induced downstream signalling events including PI3K/Akt and P38 MAPK that led to reduced viability, apoptosis and cell dysfunction of cardiomyocytes.
We identified PI3K/Akt as well as P38 MAPK signalling pathways played an important role in CIC. Our study provides a reliable model with cellular phenotype associated with CIC, which enhances discovery of new cardioprotective drugs by pinpointing the underlying molecular basis.
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